Spatial and molecular control of HIV-1 assembly and budding

Combination antiretroviral therapy has transformed HIV-1 infection into a chronic, manageable condition, yet lifelong treatment remains necessary due to the persistence of latent reservoirs and the continual emergence of drug-resistant variants. Most approved antivirals target early entry or enzymatic steps, leaving the late phase of replication—Gag trafficking, lattice assembly, membrane scission, envelope incorporation, and protease-driven maturation—underexplored as a target for antiviral inhibitors. Recent advances in cryo-electron microscopy, cryo-electron tomography, single-molecule and live-cell imaging, and integrative systems-level approaches reveal that HIV-1 assembly and egress are not linear, virus-autonomous reactions. Instead, they are spatially and temporally coordinated processes embedded within host cellular architecture. Viral RNA scaffolding, plasma membrane composition and curvature, microdomain identity, cytoskeletal dynamics, and endosomal sorting complexes required for transport (ESCRT)-mediated membrane fission are tightly coupled to Gag lattice formation, establishing regulated checkpoints that vary across cell types and tissue microenvironments. This host-integrated framework reframes HIV-1 morphogenesis as a systems-level process and highlights structurally constrained, host-dependent nodes as promising targets for next-generation antiviral strategies.

Authors

Institutions

Publication Details

Journal
mBio
Published
2026-11-19
DOI
https://doi.org/10.1128/mbio.02690-26
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Spatial and molecular control of HIV-1 assembly and budding

Xinhong Dong, Gehad Elkady
mBio
HIV Research and Treatment
article

Spatial and molecular control of HIV-1 assembly and budding

Xinhong Dong, Gehad Elkady
article en

Abstract

Combination antiretroviral therapy has transformed HIV-1 infection into a chronic, manageable condition, yet lifelong treatment remains necessary due to the persistence of latent reservoirs and the continual emergence of drug-resistant variants. Most approved antivirals target early entry or enzymatic steps, leaving the late phase of replication—Gag trafficking, lattice assembly, membrane scission, envelope incorporation, and protease-driven maturation—underexplored as a target for antiviral inhibitors. Recent advances in cryo-electron microscopy, cryo-electron tomography, single-molecule and live-cell imaging, and integrative systems-level approaches reveal that HIV-1 assembly and egress are not linear, virus-autonomous reactions. Instead, they are spatially and temporally coordinated processes embedded within host cellular architecture. Viral RNA scaffolding, plasma membrane composition and curvature, microdomain identity, cytoskeletal dynamics, and endosomal sorting complexes required for transport (ESCRT)-mediated membrane fission are tightly coupled to Gag lattice formation, establishing regulated checkpoints that vary across cell types and tissue microenvironments. This host-integrated framework reframes HIV-1 morphogenesis as a systems-level process and highlights structurally constrained, host-dependent nodes as promising targets for next-generation antiviral strategies.

mBio
Meharry Medical College (US)
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon